In tropical countries, malaria and hypertension are common diseases of pregnancy. They have physiopathologic similarities such as placental ischemia, endothelial dysfunction, and production of proinflammatory cytokines. Recent findings suggested their possible link. The authors conducted a case-control study to explore the relation between malaria and hypertension at Guediawaye, a hypoendemic malarial setting in Senegal. Cases were pregnant women admitted to the delivery unit for hypertension. Controls were pregnant women admitted for normal delivery, without any history of hypertension or proteinuria during the present pregnancy. Malarial infection was determined by placental tissue examination. From January to December 2002, 77 cases of gestational hypertension, 113 cases of preeclampsia, 59 cases of eclampsia, and 241 controls were enrolled. Placental malarial infection (PMI) was present in 14 cases (6.3%) and in 15 controls (6.2%). The prevalence of PMI was 4.6% for eclampsia, 4.0% for preeclampsia, and 11.6% for gestational hypertension. In multivariate analysis, PMI appeared to be an independent risk factor for gestational hypertension (adjusted odds ratio ¼ 2.7, 95% confidence interval: 1.0, 7.6). The authors found an association between PMI and nonproteinuric hypertension in women living in a malaria-hypoendemic area. The exact significance of such relation should be clarified in further studies in different settings of malarial endemicity.
In areas of stable endemic malarial transmission, Plasmodium falciparum infection during pregnancy is usually asymptomatic. It is characterized by sequestration of parasites in the placenta. Massive sequestration of parasites in the placenta leads to placental ischemia, increases production of proinflammatory cytokines, and increases endothelial dysfunction (1, 2) . The effects of malaria in pregnancy have been well described. It has been documented that malarial infection during pregnancy is a major cause of low birth weight babies and maternal anemia (3) (4) (5) (6) (7) . Moreover, malaria is considered to be an indirect cause of maternal death (8) .
Hypertension diseases (gestational hypertension, preeclampsia, and eclampsia) are the most common medical disorders during pregnancy (9) . In West Africa, hypertension during pregnancy is the third leading cause of maternal severe morbidity (after hemorrhage and dystocia) and the second leading cause of maternal death principally due to eclampsia (8) . Risk factors for hypertension during pregnancy have been well studied in women living in developed countries. These risk factors might be different among subSaharan Africa's women who have encountered a more difficult context including poverty, lack of access to equipped maternal health care centers, and high malarial exposure. It might be interesting to explore such specific risk factors.
Some findings suggest a possible link between placental malarial infection (PMI) and preeclampsia. In 1936, Wickramasuriya described an ''epidemic of toxemic pregnancies following the wake of the malaria epidemic'' (10, p. 56). Additionally, in sub-Saharan Africa, the rates of both preeclampsia and malaria increase during the rainy season: In Senegal, a highly seasonal malarial transmission area, 2 studies have observed a higher incidence of preeclampsia during the peak of malarial transmission during the rainy season (11, 12) . A strong association was found between active malarial infection (identified by peripheral parasitemia) and bilateral notching of the uterine artery Doppler waveforms in late pregnancy (32-35 weeks' gestation) as observed in women with preeclampsia (13) . In The Gambia, a 5.4-fold increase in maternal deaths due to eclampsia during the malarial season was observed (14) .
Moreover, the pathophysiologic mechanisms of preeclampsia and PMI are similar, including placental ischemia, endothelial dysfunction, and production of proinflammatory cytokines (2, (15) (16) (17) (18) (19) (20) . More recently, in 2006 in Tanzania, Muehlenbachs et al. (21) have suggested that maternal-fetal conflict involving the inflammatory mediator, vascular endothelial growth factor pathway, occurs during placental malaria and that its inhibitor, soluble vascular endothelial growth factor receptor 1, may be involved in a possible relation between chronic PMI and hypertension in primigravidas.
In this case-control study in an urban low malarial transmission area, we aimed to explore the relation between PMI and hypertension during pregnancy.
MATERIALS AND METHODS

Study area
The study was undertaken at the maternity ward of Roi Baudouin Maternity Health Centre in Guédiawaye in the northern suburbs of Dakar, Senegal. The population of the district of Guédiawaye is estimated at 250,000. However, the maternity ward's geographic location and its technical capacity make it the first referral point for many of the primary maternity services in the bordering districts of Pikine and Mbao, covering a total population estimated at over 1 million. Each year, about 6,000 pregnant women deliver at the maternity ward. In 2002, the maternity ward was able to provide care for low-and high-risk pregnancies (routine, basic, and comprehensive essential obstetric care) but not intensive care such as artificial ventilation, dialysis, or other invasive interventions. If needed, the district maternity ward refers patients to the university hospital 15 km away.
The area is bordered by a permanent marsh (Niayes). Malaria is highly seasonal and hypoendemic (one infective bite/person/year) (22) . One previous study found that placental malarial prevalence peaks were noted from September to December with a median prevalence of 10% (23) .
In 2002, the Senegalese Ministry of Health recommendation for malarial prophylaxis during pregnancy was based on chloroquine (300-600 mg/week) from the first antenatal visit to 2 months after delivery.
Study design
From January 2002 to January 2003, we conducted a case-control study. Cases were pregnant women admitted to the delivery unit for gestational hypertension with or without significant proteinuria, preeclampsia, or eclampsia. Controls were pregnant women admitted for normal delivery, without any blood pressure values greater than 139/89 or proteinuria recorded in the pregnant health card during the antenatal visits and at the time of delivery.
Diagnosis was assessed by obstetricians or midwives. According to routine practices in this maternity ward, 2 measures of blood pressure were done using a sphygmomanometer. Blood pressure measures were taken first at the time of admission after a 10-minute rest and far from a uterine contraction; the second measure of blood pressure was taken between 30 and 60 minutes later in the same conditions. The higher blood pressure value was recorded. Proteinuria (albumin) was detected in a fresh urine sample before active labor by semiquantitative dipsticks (Albustix; Bayer Corporation, Elkhart, Indiana).
Cases were classified into 3 groups according to National High Blood Pressure Education Program guidelines (24) : first, gestational hypertension (systolic blood pressure of 140 mm Hg or diastolic blood pressure of 90 mm Hg and albumin dosage of 2); second, preeclampsia (systolic blood pressure of 140 mm Hg or diastolic blood pressure of 90 mm Hg and albumin dosage of >2, without seizures); and third, eclampsia (when seizures or coma was associated with high systolic blood pressure of 140 mm Hg or diastolic blood pressure of 90 mm Hg with proteinuria).
Cases and controls were matched for age (<20, 20-29, 30 years), parity (1, 2, 3-5, 6 births), and date of delivery (within 2 weeks).
Exposure of interest
PMI was the main exposure factor. PMI was determined by thick blood film from placental blood taken via an incision on a maternal facing surface of the placenta adjacent to the site of biopsy removal, which was Giemsa stained and examined in light microscopy by 2 trained microscopists. Additionally, a biopsy specimen of the placenta was taken from the maternal surface. Placenta pieces were fixed into 10% neutral buffered formalin. After fixation, sections were cut onto slides, processed, and stained with Giemsa and/ or hematoxylin-eosin. Histologic examinations were performed by an experienced histopathologist without knowledge of the physician's diagnosis. We defined 2 categories for PMI: first, past infection (presence of malarial pigment in macrophages or fibrinoid without parasites); and second, recent infection (active or chronic: observation of infected red blood cells with or without malarial pigment in macrophages or fibrinoid).
Compliance with malarial chloroquine chemoprophylaxis recommendations was assessed by both interview and detection of chloroquine in a fresh urine sample by using the Haskins and Mount methyl-orange method. Prophylaxis was considered as ''regular'' if the woman took chloroquine at a dosage of 300-600 mg/week at least 3 weeks/month from the first antenatal visit to delivery. Otherwise, prophylaxis was considered ''irregular.'' Information about the pregnancy, medical and obstetric history, sociodemography, and some other risk factors was obtained from the pregnant woman's health card records and interviews. The interviews were conducted after delivery in the ''Suite de Couches ward'' for both cases and controls. In the rare situations (<10%) where women were not able to respond themselves because of the medical situation, interviews were conducted with the accompanying person (husband, mother, or sister depending on who lives with her). The interviews were conducted by trained project nurses/ midwives using a standardized questionnaire.
Ethical issues
Approval was granted by the ethics committees of the Senegalese Ministry of Health. An informed oral and signed consent was obtained from the patients or parents (if the patient was unconscious). All information obtained from participants was kept confidential. Individual medical records were stored in locked cupboards at the Institut de Recherche pour le Développement. The study covered the cost of delivery charges for each pregnant woman enrolled in this study.
Statistical analysis
Data were entered and checked for errors by using the Epi Info 6 microcomputer program (Centers for Disease Control and Prevention, Atlanta, Georgia). PMI and other exposure factors (socioeconomic variables, clinical findings, past pregnancy outcome, family history of hypertension, and chloroquine chemoprophylaxis) were compared between cases and controls. Qualitative variables were compared by using the classic chi-square test and the chi-square trend test, and quantitative variables were compared by using the nonparametric Mann-Whitney test. Analysis of the association between PMI or other risk factors and the occurrence of hypertension disease was made by calculation of the matched odds ratio and its 95% confidence interval. Variables associated with preeclampsia or gestational hypertension at a threshold of less than 0.20 in the bivariate analysis and matched variables (age, parity, and period of delivery) were included in a logistic regression model. We built 3 separate nonconditional logistic regression analyses: one for gestational hypertension, one for preeclampsia, and one for eclampsia. For all of the analyses, the level of significance was fixed at 0.05. Analysis was performed by using STATA7 software (StataCorp LP, College Station, Texas).
RESULTS
Characteristics of the study population
From January 2002 to January 2003, we enrolled 249 cases (77 gestational hypertension, 113 preeclampsia, and 59 eclampsia) and 241 controls. The 2002 Maternity Activity Report indicates that 6,426 women had been admitted for delivery at the Roi Baudouin Maternity Health Centre, giving a total of 259 preeclampsia and 102 eclampsia cases.
Our recruitment rate for cases was approximately 69% (249/ 259 þ 102).
The majority of cases (n ¼ 228; 91.6%) and controls (n ¼ 232; 96.3%) were residents of the Guédiawaye department. Of note, 21 cases (8.4%) were referred by maternity wards that were downtown or in neighboring suburbs. There was no difference between cases and controls in terms of the following: 1) the recruitment period (47.4% of cases and 49.4% of controls (P ¼ 0.66) being recruited during the rainy malarial transmission season) and 2) the use of malarial prevention (i.e., chloroquine chemoprophylaxis and bednets). All characteristics for cases and controls are reported in Table 1 .
Only
Univariate analysis
Only the 223 cases and 240 controls who had placental tissue examination were included in the statistical analysis hereafter.
PMI was present in 14 cases (6.3%) and in 15 controls (6.2%). P. falciparum was the only Plasmodium species found in malaria-infected placentas.
Among the 14 infected cases, histologic examinations showed 8 (57%) past infections and 6 (43%) recent/chronic infections. For the controls, 7 presented past infection (46.7%) and 8 (53.3%) had recent/chronic infection. Regarding type of hypertension, the prevalence of PMI was 3.7% (2 of 53) for eclampsia, 4.0% (4 of 101) for preeclampsia, and 11.6% (8 of 69) for gestational hypertension. The prevalence of recent/chronic PMI was, respectively, 2.1% (1 of 48), 2.9% (3 of 101), and 5.9% (4 of 69). For past PMI, the prevalence was 1.9% (1 of 53), 1% (1 of 101), and 5.9% (4 of 69), respectively. There was no difference in the distribution of past and recent/chronic infection among the different groups (P ¼ 0.69). The odds ratios of having PMI when hypertension disease was present were 0.7 (95% confidence interval (CI): 0.1, 3.7; P ¼ 0.6) for eclampsia, 0.6 (95% CI: 0.2, 2.1; P ¼ 0.5) for preeclampsia, and 2.0 (95 % CI: 0.7, 1.2; P ¼ 0.14) for gestational hypertension.
Regarding environmental, socioeconomic, and host risk factors in the different hypertension categories, we found, as expected, that women with eclampsia were younger than those with preeclampsia or gestational hypertension. The mean ages were, respectively, 23.7 (standard deviation, 6.8), 27.0 (standard deviation, 6.7), and 27.8 (standard deviation, 6.9) years. Similarly, the proportion of primiparous women was higher in the eclampsia group (n ¼ 30; 56.6%) than in the preeclampsia (n ¼ 39; 34.5%) and gestational hypertension (n ¼ 29; 42.0%) groups.
The socioeconomic factors were equally distributed among the 3 categories of hypertension. Of note, those with gestational hypertension were more likely to be illiterate and unmarried. The proportion of women who did not own an economic resource was higher among those with preeclampsia than with gestational hypertension and eclampsia.
Some obstetric factors were found to be associated with the 3 hypertension diseases: twin pregnancy, lack of antenatal visits, and the presence of family history of hypertension. History of previous poor pregnancy outcomes, that is, any outcome of a previous pregnancy that was not a normal delivery (>38 weeks, no cesarean, no instrumental delivery) of a live newborn, was associated with preeclampsia and gestational hypertension but not with eclampsia (Table 2) .
Of note, women with gestational hypertension reported fever or other symptoms suggestive of malaria during their pregnancy more frequently than controls did (P ¼ 0.038).
Multivariate analysis
For each regression model, the control group was represented by all the controls regardless of matching. PMI appeared to be an independent risk factor for gestational hypertension (adjusted odds ratio (AOR) ¼ 2.7, 95% CI: 1.0, 7.6). Other risk factors for gestational hypertension were mainly host factors such as past poor pregnancy outcomes (AOR ¼ 3.1, 95% CI: 1.5, 6.4) and family history of hypertension (AOR ¼ 2.8, 95% CI: 1.5, 5.3). The only socioeconomic factor found was single marital status (single, widowed, divorced) (AOR ¼ 2.2, 95% CI: 1.2, 4.3).
PMI was not associated with eclampsia and preeclampsia. Family history of hypertension was associated with both eclampsia (AOR ¼ 2.2, 95% CI: 1.1, 4.5) and preeclampsia (AOR ¼ 1.9, 95% CI: 1.1, 3.2), respectively. Previous poor pregnancy outcome was associated with preeclampsia but not eclampsia (Table 3) .
DISCUSSION
We have found a relation between PMI and gestational hypertension in pregnant women living in a malariahypoendemic setting in Senegal. This suggests that malaria during pregnancy may be an independent risk factor for hypertensive disorder. A possible mechanism is that PMI leads to placental ischemia and loss of placental integrity, which leads to endothelial cell dysfunction and cytokine activation (20) .
Our finding is consistent with the observation of Sartelet et al. (11) of a 3.3-fold increase in the risk of PMI within women with diastolic blood pressure greater than or equal to 90 mm Hg compared with controls, where it was less than 90 mm Hg. The difference between our study and that of Sartelet et al. is that we have classified hypertensive women according to the presence or absence of significant proteinuria. This allowed us the possibility of identifying the specific subgroup of hypertension that was associated with malaria.
We did not find an association between PMI and preeclampsia or eclampsia, contrary to what is usually thought (11) (12) (13) (14) (20) (21) . Such difference may be related to local clinical practices in Senegalese maternity services. Preeclampsia and eclampsia are usually clinically alarming situations that can be confused with severe malaria. For that reason, many medications, including intravenous quinine perfusion, are prescribed to such women and probably lead to clearing parasites from the placenta. This is not the case for gestational hypertension, which is associated with a less alarming clinical picture and does not imply intensive care such as quinine infusion.
The timing of the placental infection (recent/chronic infection vs. past infection) does not seem to have an effect on the relation between PMI and gestational hypertension. It is admitted that determinants of pregnancy-induced hypertension, such as abnormal placentation and reduction of placental perfusion, occur at the beginning of the second trimester of pregnancy (15, 18) . This suggests that the PMI observed at the time of delivery may reflect an earlier infection in the middle of the pregnancy (25) .
We have found some other specific risk factors for hypertensive diseases in women living in malaria-endemic settings, such as lack of antenatal follow-up, previous poor pregnancy outcome, and family history of hypertension (8, 18) . This indicates the need to improve the public maternal health-care system. These factors are detectable during a Before malarial transmission (May-July); during malarial transmission (August-November); after malarial transmission (DecemberApril).
antenatal visits and do not require any resources other than qualified practitioners, systematic standardized interviews, and local standard operating procedures for antenatal visits.
Our results may have been limited by unexpected events impacting the epidemiology of malaria in this particular setting. Instead of an expected 10% median prevalence of PMI, we noticed an approximate 5% prevalence of PMI due to the combination of low rainfall measures, insecticidetreated manures, and bednet distribution in the context of yellow fever epidemic control measures. Because of field constraints, we failed to perfectly match cases and controls for the multivariate analysis. Especially, we did not find matched controls for primiparous cases aged greater than 30 years, and we did not match the 26 cases without placental tissue. Ultimately, instead of 249 case-control pairs, we had only 179. We opted to perform a nonconditional logistic regression analysis instead of a strict matched case-control analysis approach to preserve sufficient statistical power. Globally, the results of the matched adjusted odds ratios did not differ from those obtained in the nonconditional multivariate analysis: For gestational hypertension, the matched adjusted odds ratio was 2.98 (95% CI: 1.0, 8.8). For preeclampsia and eclampsia, the matched adjusted odds ratios were, respectively, 0.8 (95% CI: 0.3, 4.8) and 1.1 (95% CI: 0.3, 7.0).
Despite these limits, we have emphasized the problem of a link between PMI and nonproteinuric hypertension. The exact significance of the role of malaria in the occurrence of hypertension must be balanced with other known risk factors for poor pregnancy outcomes encountered by pregnant women in developing countries, such as heavy work load, poor and salty diet, and instability. All these conditions, including malaria, are related to poverty. The results have several implications. First, they have confirmed that detection and treatment of P. falciparum infection during antenatal visits may be useful in reducing the occurrence of placental vascular pathology. Additionally, it is imperative to improve the quality of services in antenatal clinics so that they are able to detect women who are at risk for complications such as eclampsia and preeclampsia. Furthermore, research in different malarial settings (high, middle, and low transmission) might contribute to testing the ''dose-response'' relation between malaria and risk of adverse outcomes and to determining the real impact of malaria in pregnancy. Finally, the active mechanisms of placental dysregulation with malarial infection must be further examined, as they may provide valuable keys to novel therapeutic design in the realm of pregnancy-induced hypertension research.
